Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Jun 25, 2014 Theratechnologies to receive 4.1 million dollar payment from Revenue Canada Jun 10, 2014 Theratechnologies Obtains U.S. Patent Term Extension for Tesamorelin May 23, 2014 Additional Update on Availability of EGRIFTA® (tesamorelin for injection) in the United States May 21, 2014 Announcements in Conjunction With Theratechnologies Annual Meeting May 20, 2014 Update on Availability of EGRIFTA™ in the United States May 01, 2014 Theratechnologies regains rights to EGRIFTA (tesamorelin for injection) in the United States Apr 30, 2014 Health Canada approves EGRIFTA Apr 14, 2014 Theratechnologies announces financial results for first quarter of 2014 Feb 27, 2014 Theratechnologies announces financial results for fiscal year 2013 Feb 25, 2014 Theratechnologies to announce financial results for fiscal year 2013 First page « Previous page ‹ … Page 30 Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Next page › Last page » Displaying 341 - 350 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
May 23, 2014 Additional Update on Availability of EGRIFTA® (tesamorelin for injection) in the United States
May 01, 2014 Theratechnologies regains rights to EGRIFTA (tesamorelin for injection) in the United States
